DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Lucas T, Astorga R.
The Spanish-Portuguese MultiCentre Autogel Study Group on Acromegaly. Efficacy of lanreotide Autogel administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: a phase III trial.
Clin Endocrinol 2006; 65: 320-326
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.